Você esta aqui:Home > Therapeutics (antigo) > Marijuana Use and Pregnancy

J Cannabis Ther 2002(3/4):083-102

Marijuana Use and Pregnancy

Marijuana Use and Pregnancy

Author
P.A. Fried

Abstract
In spite of marijuana being the most widely used illegal drug among women of reproductive age there is a relative paucity of literature dealing with this topic. Of the data available, particularly in offspring beyond three years of age, most is generated by two ongoing cohort studies with very different populations. Both have reported similar findings. Up to approximately 3 years of age there appears to be very little impact upon the offspring. Beyond that age, in utero cannabis exposure does not impact upon standardized derived IQ scores but is negatively associated with attentional behavior and visual analysis/hypothesis testing. These findings are hypothesized as prenatal marijuana exposure having a negative influence on aspects of executive function-a "top-down," multifaceted cognitive construct involved in organizing and integrating specific cognitive and output processes over a interval of time. The results and their interpretation are examined in terms of behavioral teratogenic effects (or lack of effects) during the various developmental stages of the offspring, the non-unitary nature of executive function, cannabis receptors, and the consequences of chronic marijuana use in the non-pregnant population.


Keywords
Prenatal marijuana exposure, pregnancy, executive function, prefrontal lobe, longitudinal studies, IQ, visual perception, attention

PDF do texto completo ]

Free Online Events 2020

You can find all information here.

The IACM is holding a free webinar series and a free anniversary online meeting from October to November 2020

All webinars will be held in English with subtitles in German, French, Spanish, and Portuguese. All webinars will be available online until March 2021

The anniversary online meeting to celebrate the IACM's 20th anniversary and to honour the 90th birthday of Raphael Mechoulam will be a live session only on the 5th November 2020.

The speakers in the webinar series are Donald I. Abrams, Bonni Goldstein, Franjo Grotenhermen, Manuel Guzmán, Raphael Mechoulam, Kirsten Müller-Vahl, Roger Pertwee, Daniele Piomelli, and Ethan Russo.

You can find all information here.

Conferência 2021

A 12ª Conferência da IACM sobre Canabinoides em Medicina será realizada em Basileia, Suíça, de 14 a 16 de Outubro de 2021.

Members only

Regular members can sign up for the new member area of the IACM to access exclusive content.

You need to become a regular member of the IACM to access the new member area.

IACM on Twitter

Follow us on twitter @IACM_Bulletin where you can send us inquiries and receive updates on research studies and news articles.